Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

The study demonstrates that PAC-MANN-1 outperforms the widely used CA 19-9 biomarker, offering greater accuracy in detecting all stages of PDAC. The assay is particularly promising for identifying ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

A pancreatic elastase test ... The fecal elastase test involves collecting and sending a stool sample to a laboratory. If the test reveals a low amount of elastase in your stool, it could indicate ...

Mainz Biomed has the exclusive rights to develop a test for early pancreatic cancer detection using Liquid Biosciences' biomarkers.

The new blood-based assay PAC-MANN-1 (protease activity–based cancer ... or pancreatic neoplasia. To determine whether the probe was specific to PDAC, researchers compared longitudinal samples ...

This latest study from a collaboration between Cedars- Sinai Medical Center, University of Southern California, and the Keck School of Medicine, which analyzed blood samples from seven PDAC ...

Pancreatic cancer has a poor survival rate of approximately 10 per cent over five years and is expected to be the third leading cause of cancer-related deaths in Canada in the next few years.